Name | promegestone |
---|---|
Synonyms |
R5020
(8S,13S,14S,17S)-13,17-dimethyl-17-propanoyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Promegestona Promegestone 17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione RU5020 Promegestonum promegestrone |
Description | Promegestone (R-5020), a progestin, is a potent progesterone receptor (PR) agonist. Promegestone has the potential for endocrine regulation and cancer research[1]. |
---|---|
Related Catalog | |
In Vitro | Promegestone (R-5020; 1 nM) is efficient ligand with a full agonist response profile and a low EC50 of 0.33 nM) in HELN-hPR while it only partially induced luciferase activity in U2OS-zfPR (EC50=1.93 nM)[1]. Promegestone is inactive in HELN cells that express luciferase but no functional receptor[1]. Promegestone (10 nM) robustly stimulates SLC37A2 expression in cells expressing SUMO-deficient PR, but not in cells expressing WT PR in T47D cell models[3]. |
In Vivo | Promegestone (R-5020; 8 mg/kg; intramuscularly)-treated pregnant mice on day 18 postbreeding has the least deterioration in extracellular collagen (lowest OD) and highest cell density compared to other groups on the day before birth[2]. |
References |
Density | 1.09 g/cm3 |
---|---|
Boiling Point | 486.8ºC at 760 mmHg |
Melting Point | 152° |
Molecular Formula | C22H30O2 |
Molecular Weight | 326.47200 |
Flash Point | 180.4ºC |
Exact Mass | 326.22500 |
PSA | 34.14000 |
LogP | 5.17780 |
Index of Refraction | 1.553 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|